International Prospective REgistry on Pre-pectorAl Breast REconstruction
NCT ID: NCT05817175
Last Updated: 2025-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1236 participants
OBSERVATIONAL
2023-09-12
2027-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Opting for Breast Reconstruction After Mastectomy or Not: Search for Influencing Factors
NCT03039348
Mastectomy With Retention of the Nipple-areola Complex, Robot-assisted or Not, and / or Immediate or Seconday Reconstruction by Latissimus Dorsi Flap, Robot-assisted or Not.
NCT04457167
Pre Pectoral Implant for Immediate Breast Reconstruction Using Single Port Endoscopy in Prophylactic Indication
NCT03838549
Evaluation of the Effectiveness of Prepectoral Breast Reconstruction
NCT05125991
Mastectomy in Ambulatory Breast Surgery
NCT03003169
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pre-pectoral breast reconstruction
to prospectively evaluate the utilization of the pre-pectoral approach, and evaluate oncological and aesthetic outcomes related to each type of surgical technique and the use of postmastectomy radiation therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed informed consent form
* Patients undergoing mono or bilateral therapeutic mastectomy
* Patients undergoing pre-pectoral implant-based breast reconstruction with implant or expander with or without mesh
Exclusion Criteria
* Patients not suitable for surgical treatment
* Patients undergoing subpectoral reconstruction
* Patients undergoing breast reconstruction with autologous tissue.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
EUBREAST ETS
UNKNOWN
IRCCS San Raffaele
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oreste Davide Gentilini
Professor, Head of Breast Surgery Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oreste D Gentilini, Dr
Role: STUDY_CHAIR
IRCCS San Raffaele
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univesidad de Buenos Aires
Buenos Aires, , Argentina
Mansoura Insurance
Al Mansurah, , Egypt
Mansoura Oncology
Al Mansurah, , Egypt
National ans Kapodistrian University of Athens
Athens, , Greece
Ospedale San Raffaele
Milan, MI, Italy
Fondazione Policlinico Universitario Agostino Gemelli
Roma, RM, Italy
University Hospital of Karol Marcinkowski
Zielona Góra, , Poland
Prof. Dr. Ion Chiricuta Institute of Oncology
Cluj-Napoca, , Romania
Hospital del Mar
Barcelona, , Spain
Marmara University School of medicine
Istanbul, , Turkey (Türkiye)
University Hospitals of Leicester
Leicester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Eduardo Gonzalez, MD
Role: primary
Khaled Ali
Role: primary
Khaled Ali, MD
Role: primary
Michalis Kontos, MD
Role: primary
Gianluca Franceschini, MD
Role: primary
Dawid Murawa
Role: primary
Maximilian Muntean, MD
Role: primary
Maria Del Mar Bernet-Tomas, MD
Role: primary
Umit Ugurlu, MD
Role: primary
Tim Rattay
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EUBREAST-11R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.